Moderna Shares Drop 5.0%, Wiping Out $3.0 Billion as $2 Billion Convertible Notes Offering Challenges Cancer-Vaccine Surge
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Moderna Shares Drop 5.0%, Wiping Out $3.0 Billion as $2 Billion Convertible Notes Offering Challenges Cancer-Vaccine Surge
CAMBRIDGE, Massachusetts, August 27, 2026, 10:15 (EDT) Moderna (MRNA.O) stock slid 5.0% on Thursday, shaving $3.0 billion off its market value, after the company announced a $2 billion convertible notes sale, testing investor appetite following a recent rally in its cancer-vaccine business. Shares of Moderna declined 5.0% to $142.20 during Thursday morning trade.The firm put…
The US biotechnology laboratory Moderna has announced its intention to carry out, depending on market conditions and other factors, a private placement of $2 billion (€1,715 million) in convertible senior bonds with maturity in 2032 among "persons who are reasonably considered qualified institutional buyers".
Company has informed that it intends to use resources for general purposes, such as investments in the business of oncology and payment of debts
The biotechnology laboratory announced its intention to carry out, depending on market conditions and other factors, a private placement of $2 billion in convertible senior bonds with maturity in 2032.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
